-
Something wrong with this record ?
Structural diversity of solid dispersions of acetylsalicylic acid as seen by solid-state NMR
O. Policianova, J. Brus, M. Hruby, M. Urbanova, A. Zhigunov, J. Kredatusova, L. Kobera,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
24417442
DOI
10.1021/mp400495h
Knihovny.cz E-resources
- MeSH
- Aspirin chemistry MeSH
- Calorimetry, Differential Scanning MeSH
- Magnetic Resonance Spectroscopy * MeSH
- Molecular Structure MeSH
- Suspensions chemistry MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Solid dispersions of active pharmaceutical ingredients are of increasing interest due to their versatile use. In the present study polyvinylpyrrolidone (PVP), poly[N-(2-hydroxypropyl)-metacrylamide] (pHPMA), poly(2-ethyl-2-oxazoline) (PEOx), and polyethylene glycol (PEG), each in three Mw, were used to demonstrate structural diversity of solid dispersions. Acetylsalicylic acid (ASA) was used as a model drug. Four distinct types of the solid dispersions of ASA were created using a freeze-drying method: (i) crystalline solid dispersions containing nanocrystalline ASA in a crystalline PEG matrix; (ii) amorphous glass suspensions with large ASA crystallites embedded in amorphous pHPMA; (iii) solid solutions with molecularly dispersed ASA in rigid amorphous PVP; and (iv) nanoheterogeneous solid solutions/suspensions containing nanosized ASA clusters dispersed in a semiflexible matrix of PEOx. The obtained structural data confirmed that the type of solid dispersion can be primarily controlled by the chemical constitutions of the applied polymers, while the molecular weight of the polymers had no detectable impact. The molecular structure of the prepared dispersions was characterized using solid-state NMR, wide-angle X-ray scattering (WAXS), and differential scanning calorimetry (DSC). By applying various (1)H-(13)C and (1)H-(1)H correlation experiments combined with T1((1)H) and T1ρ((1)H) relaxation data, the extent of the molecular mixing was determined over a wide range of distances, from intimate intermolecular contacts (0.1-0.5 nm) up to the phase-separated nanodomains reaching ca. 500 nm. Hydrogen-bond interactions between ASA and polymers were probed by the analysis of (13)C and (15)N CP/MAS NMR spectra combined with the measurements of (1)H-(15)N dipolar profiles. Overall potentialities and limitations of individual experimental techniques were thoroughly evaluated.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014543
- 003
- CZ-PrNML
- 005
- 20150428112703.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/mp400495h $2 doi
- 035 __
- $a (PubMed)24417442
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Policianova, Olivia $u Institute of Macromolecular Chemistry , Academy of Sciences of the Czech Republic, Heyrovského nám. 2, 162 06 Praha 6, Czech Republic.
- 245 10
- $a Structural diversity of solid dispersions of acetylsalicylic acid as seen by solid-state NMR / $c O. Policianova, J. Brus, M. Hruby, M. Urbanova, A. Zhigunov, J. Kredatusova, L. Kobera,
- 520 9_
- $a Solid dispersions of active pharmaceutical ingredients are of increasing interest due to their versatile use. In the present study polyvinylpyrrolidone (PVP), poly[N-(2-hydroxypropyl)-metacrylamide] (pHPMA), poly(2-ethyl-2-oxazoline) (PEOx), and polyethylene glycol (PEG), each in three Mw, were used to demonstrate structural diversity of solid dispersions. Acetylsalicylic acid (ASA) was used as a model drug. Four distinct types of the solid dispersions of ASA were created using a freeze-drying method: (i) crystalline solid dispersions containing nanocrystalline ASA in a crystalline PEG matrix; (ii) amorphous glass suspensions with large ASA crystallites embedded in amorphous pHPMA; (iii) solid solutions with molecularly dispersed ASA in rigid amorphous PVP; and (iv) nanoheterogeneous solid solutions/suspensions containing nanosized ASA clusters dispersed in a semiflexible matrix of PEOx. The obtained structural data confirmed that the type of solid dispersion can be primarily controlled by the chemical constitutions of the applied polymers, while the molecular weight of the polymers had no detectable impact. The molecular structure of the prepared dispersions was characterized using solid-state NMR, wide-angle X-ray scattering (WAXS), and differential scanning calorimetry (DSC). By applying various (1)H-(13)C and (1)H-(1)H correlation experiments combined with T1((1)H) and T1ρ((1)H) relaxation data, the extent of the molecular mixing was determined over a wide range of distances, from intimate intermolecular contacts (0.1-0.5 nm) up to the phase-separated nanodomains reaching ca. 500 nm. Hydrogen-bond interactions between ASA and polymers were probed by the analysis of (13)C and (15)N CP/MAS NMR spectra combined with the measurements of (1)H-(15)N dipolar profiles. Overall potentialities and limitations of individual experimental techniques were thoroughly evaluated.
- 650 _2
- $a Aspirin $x chemie $7 D001241
- 650 _2
- $a diferenciální skenovací kalorimetrie $7 D002152
- 650 12
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a suspenze $x chemie $7 D013535
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brus, Jiri
- 700 1_
- $a Hruby, Martin
- 700 1_
- $a Urbanova, Martina
- 700 1_
- $a Zhigunov, Alexander
- 700 1_
- $a Kredatusova, Jana
- 700 1_
- $a Kobera, Libor
- 773 0_
- $w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 11, č. 2 (2014), s. 516-30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24417442 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150428113006 $b ABA008
- 999 __
- $a ok $b bmc $g 1072124 $s 897421
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 11 $c 2 $d 516-30 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
- LZP __
- $a Pubmed-20150420